Maggie L Westfal1, Allan M Goldstein. 1. aDepartment of Surgery bDepartment of Pediatric Surgery, Massachusetts General Hospital, Harvard Medical School cCenter for Neurointestinal Health, Massachusetts General Hospital, Boston, Massachusetts, USA.
Abstract
PURPOSE OF REVIEW: Neurointestinal diseases are increasingly recognized as causes of significant gastrointestinal morbidity in children. This review highlights the most common pediatric enteric neuropathies and their diagnosis and management, emphasizing insights and discoveries from the most recent literature available. RECENT FINDINGS: The embryologic and histopathologic causes of enteric neuropathies are varied. They range from congenital aganglionosis in Hirschsprung disease, to autoimmune-mediated loss of neuronal subtypes in esophageal achalasia and Chagas disease, to degenerative neuropathies in some cases of chronic intestinal pseudo-obstruction and gastroparesis. Increased awareness of the clinical presentation and diagnostic evaluation of these conditions is essential as it allows for earlier initiation of treatment and improved outcomes. Most current therapies, which include medical management, neurostimulation, and operative intervention, aim to minimize the symptoms caused by these conditions. The evidence base for many of these treatments in children is poor, and multiinstitutional prospective studies are needed. An innovative therapy on the horizon involves using neuronal stem cell transplantation to treat the underlying disorder by replacing the missing or damaged neurons in these diseases. SUMMARY: Although recent advances in basic and clinical neurogastroenterology have significantly improved our awareness and understanding of enteric neuropathies, the efficacy of current treatment approaches is limited. The development of novel therapies, including pharmacologic modulators of neurointestinal function, neurostimulation to enhance gut motility, and neuronal cell-based therapies, is essential to improve the long-term outcomes in children with these disorders.
PURPOSE OF REVIEW: Neurointestinal diseases are increasingly recognized as causes of significant gastrointestinal morbidity in children. This review highlights the most common pediatric enteric neuropathies and their diagnosis and management, emphasizing insights and discoveries from the most recent literature available. RECENT FINDINGS: The embryologic and histopathologic causes of enteric neuropathies are varied. They range from congenital aganglionosis in Hirschsprung disease, to autoimmune-mediated loss of neuronal subtypes in esophageal achalasia and Chagas disease, to degenerative neuropathies in some cases of chronic intestinal pseudo-obstruction and gastroparesis. Increased awareness of the clinical presentation and diagnostic evaluation of these conditions is essential as it allows for earlier initiation of treatment and improved outcomes. Most current therapies, which include medical management, neurostimulation, and operative intervention, aim to minimize the symptoms caused by these conditions. The evidence base for many of these treatments in children is poor, and multiinstitutional prospective studies are needed. An innovative therapy on the horizon involves using neuronal stem cell transplantation to treat the underlying disorder by replacing the missing or damaged neurons in these diseases. SUMMARY: Although recent advances in basic and clinical neurogastroenterology have significantly improved our awareness and understanding of enteric neuropathies, the efficacy of current treatment approaches is limited. The development of novel therapies, including pharmacologic modulators of neurointestinal function, neurostimulation to enhance gut motility, and neuronal cell-based therapies, is essential to improve the long-term outcomes in children with these disorders.
Authors: Ian M Paquette; Madhulika Varma; Charles Ternent; Genevieve Melton-Meaux; Janice F Rafferty; Daniel Feingold; Scott R Steele Journal: Dis Colon Rectum Date: 2016-06 Impact factor: 4.585
Authors: Victoria A Lane; Kristine M Nacion; Jennifer N Cooper; Marc A Levitt; Katherine J Deans; Peter C Minneci Journal: J Pediatr Surg Date: 2016-08-12 Impact factor: 2.545
Authors: Marije Smits; Marinde van Lennep; Remy Vrijlandt; Marc Benninga; Jac Oors; Roderick Houwen; Freddy Kokke; David van der Zee; Johanne Escher; Anita van den Neucker; Tim de Meij; Frank Bodewes; Joachim Schweizer; Gerard Damen; Olivier Busch; Michiel van Wijk Journal: J Pediatr Date: 2015-11-23 Impact factor: 4.406
Authors: G Di Nardo; C Di Lorenzo; A Lauro; V Stanghellini; N Thapar; T B Karunaratne; U Volta; R De Giorgio Journal: Neurogastroenterol Motil Date: 2016-09-29 Impact factor: 3.598
Authors: Marco Metzger; Petra M Bareiss; Timm Danker; Silvia Wagner; Joerg Hennenlotter; Elke Guenther; Florian Obermayr; Arnulf Stenzl; Alfred Koenigsrainer; Thomas Skutella; Lothar Just Journal: Gastroenterology Date: 2009-06-21 Impact factor: 22.682
Authors: Alexandra K Eicher; Daniel O Kechele; Nambirajan Sundaram; H Matthew Berns; Holly M Poling; Lauren E Haines; J Guillermo Sanchez; Keishi Kishimoto; Mansa Krishnamurthy; Lu Han; Aaron M Zorn; Michael A Helmrath; James M Wells Journal: Cell Stem Cell Date: 2021-12-01 Impact factor: 24.633
Authors: N Nagy; N Marsiano; R S Bruckner; M Scharl; M J Gutnick; S Yagel; E Arciero; A M Goldstein; N Y Shpigel Journal: Neurogastroenterol Motil Date: 2017-09-08 Impact factor: 3.598
Authors: Simone Antunes Terra; Anderson Cesar Gonçalves; Pedro Luiz Toledo de Arruda Lourenção; Maria Aparecida Marchesan Rodrigues Journal: World J Gastroenterol Date: 2021-11-28 Impact factor: 5.742